Antitrust Antitrust

King, Lexon, Alissa used messaging and hotel meetup to share drug data, says UK CMA

By Simon Zekaria
  • 25 Jun 2020 08:41
  • 25 Jun 2020 08:53

King Pharmaceuticals, Lexon and Alissa Healthcare covertly shared sensitive data through messages and a hotel meeting to skew the UK drugs market and maintain high prices of antidepressant drug nortriptyline, the Competition and Markets Authority has said today.

The CMA had already fined the companies a total of 3.4 million pounds

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News